Understanding how well lung cancer screening works in different populations
Official title: Learning about the effectiveness of lung cancer screening in real-world target populations
Funded at Harvard School of Public Health · NIH-11004344 · Data updated 2026-11-12
This study is looking at how well lung cancer screenings work in different real-life situations, using information from various sources to find better ways to screen for lung cancer and help more people stay healthy.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard School of Public Health NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | January 1, 2024 |
| Project end | December 31, 2025 |
| Funding year | 2025 |
| Award (this year) | $128,773 |
| NIH project number | 5K99CA287059-02 |
| Project ID | NIH-11004344 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals at risk for lung cancer, particularly those from varied demographic and clinical backgrounds.
✕Less likely to help
Patients who are not at risk for lung cancer or those who have already been diagnosed with lung cancer may not benefit from this research.
What this research studies
This research investigates the effectiveness of lung cancer screening in various real-world settings, beyond the controlled environment of clinical trials. It aims to combine data from multiple sources, such as claims datasets and screening registries, to develop new methods for evaluating screening strategies. By focusing on diverse populations, the research seeks to provide insights that are more applicable to everyday clinical practice, ultimately aiming to reduce lung cancer mortality through optimized screening approaches.
Why it matters
Potential benefit: If successful, this research could lead to improved lung cancer screening strategies that save lives by detecting cancer earlier in diverse populations.
How similar studies have gone: Previous research has shown that integrating diverse data sources can enhance understanding of screening effectiveness, suggesting that this approach has potential for success.
Where this research is happening
-
Harvard School of Public Health
Boston, United States Active
Researchers
- Principal investigator: Robertson, Sarah E — Harvard School of Public Health
- Study coordinator: Robertson, Sarah E
Related research
Other NIH-funded projects on the same topics.
-
Digital health strategies to expand lung cancer screening in safety-net clinics
A funded project aims to help low-resource clinics increase the use of lung cancer screening for patients who smoke or are at risk.
-
Integrated approach to lung screening and quitting for African Americans
A multi-level program aims to boost LDCT lung cancer screening uptake and help African American smokers quit, with support from a comprehensive community-focused plan.
-
Population health approach to boost lung cancer screening at community clinics
A large Utah project aims to help community clinics reach more eligible adults to get low-dose CT lung cancer screening.
-
Group-based tobacco treatment for older adults after lung cancer screening
A study tests a group-based tobacco cessation program for older adults who are getting lung cancer screening to help them quit smoking.
-
Personalized Lung Cancer Screening for Veterans
Aimed at improving who gets screened and how lung cancer is diagnosed among Veterans using personalized tools.
-
Proteogenomic framework to improve lung cancer screening with biomarkers
A biomarker-based approach aims to refine LDCT lung cancer screening so more cancers are caught early while reducing unnecessary procedures.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.